isabelobrien, Author at European Medical Journal - Page 21 of 68

Shaji Kumar

Hema Now: Episode 14: Personalised Approaches in Myeloma Treatment

Shaji Kumar, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

An illustrated older man and woman cycling on bikes and looking happy and healthy

The clock, the germ and the gut: Pharma’s role in healthy ageing

How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial innovation.

British government buildings

UK government unveils Health Data Research Service

The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.

Dennise Broderick Galen Pharma

Galen’s Dr Dennise Broderick on why kindness isn't a weakness in business

Dr Dennise Broderick, President and Managing Director, Galen Pharma joins the GOLD podcast to discuss her life-long ambition to be a leader and how she approaches hard decisions in business.

Pharma must balance creativity and trust in 2025, says VML

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.

Colourful arrows going in different directions on a grey background

Novo Nordisk announces significant leadership reshuffle

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.

The word spotlight on a blue background

Spotlight: March 2025

From the latest news impacting the UK’s NHS to large industry acquisitions, March brought a range of impactful news.

Spoonful of technology: Jan-March 2025

Discover the latest pharma innovations, from needle-free vaccines to NHS data access and interactive case studies in medical education.

Stephen Chan

Onc Now: Episode 14: What Role Does Diet Play in Liver Cancer Prevention?

Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, shares new frontiers in liver cancer treatment.

Illustration of a heart with a monitor

Could gene therapy transform heart failure treatment?

A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.